Skip to main content

Find Clinical Trials

Home
Conditions
Stage IV Prostate Cancer

Clinical trial condition

Stage IV Prostate Cancer

Explore clinical trials studying Stage IV Prostate Cancer. Study availability and eligibility vary by location and protocol.

78 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage IV Prostate Cancer trial results

Completed

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

NCT00016107

Conditions: Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer

NCT00039104

Conditions: Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +10 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer

NCT00095667

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00089362

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +142 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Cilengitide in Treating Patients With Metastatic Prostate Cancer

NCT00103337

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00040755

Conditions: Adenocarcinoma of the Prostate, Bone Metastases, Genital Diseases, +12 more
Locations: UC Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Completed

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

NCT00096499

Conditions: Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +10 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors

NCT00074022

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details